PhagoMed Biopharma GmbH came 2nd and won €20.000 in one of the toughest contests for young European biotech companies, namely the Health Catapult of the European Institute of Innovation and Technology (EIT). The company´s synthetic lysin platform with bacterial vaginosis as a first target indication more
To use all functions of this page, please activate cookies in your browser.